Stock Events

Stock Events

CSL 

€84.15
0
-€0.78-0.92% Friday 16:02

Statistics

Day High
84.61
Day Low
83.47
52W High
153.42
52W Low
81.57
Volume
466
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10FebExpected
Q4 2025
3.39
3.42
3.45
3.48
Expected EPS
3.4820298
Actual EPS
3.3895121

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CSJ.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a global pharmaceutical company that competes with CSL in the development and marketing of medications and vaccines for various diseases.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with CSL, particularly in the immunology and blood-related product markets.
Novo Nordisk
NVO
Mkt Cap164.13B
Novo Nordisk is a leading global healthcare company that competes with CSL in the area of biopharmaceuticals, particularly in treatments for hemophilia and other disorders.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global biopharmaceutical company focused on human health, competing with CSL in areas such as rare diseases, vaccines, and immune disorders.
Baxter International
BAX
Mkt Cap8.61B
Baxter International develops, manufactures, and markets products that save and sustain the lives of people, directly competing with CSL in the plasma-derived therapies and critical care products.
Takeda Pharmaceutical
TAK
Mkt Cap59.2B
Takeda Pharmaceutical Company focuses on oncology, gastroenterology, neuroscience, and rare diseases, competing with CSL in the plasma-derived therapy market and other areas.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG is a pioneer in healthcare, competing with CSL in the biotechnology and pharmaceuticals sectors, especially in diagnostics and treatments for various diseases.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie operates in the pharmaceuticals sector, competing with CSL in the development and marketing of advanced therapies for various diseases, including immunology and oncology.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a global healthcare company that competes with CSL in the pharmaceutical and healthcare sector, focusing on vaccines, pharmaceuticals, and consumer healthcare products.
AMGEN
AMGN
Mkt Cap187.56B
Amgen is a biotechnology company that competes with CSL in the development of innovative therapeutics in areas such as cardiovascular disease, oncology, and bone health.

About

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Show more...
CEO
Mr. Andy Schmeltz
Employees
29904
Country
DE
ISIN
AU000000CSL8

Listings

MX
MX
CSLN.MX
STU
DE
CSJ.STU
F
DE
CSJ.F
F
DE
CSJA.F

0 Comments

Share your thoughts

FAQ

What is CSL stock price today?▼
The current price of CSJ.STU is €84.15 EUR — it has decreased by -0.92% in the past 24 hours. Watch CSL stock price performance more closely on the chart.
What is CSL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CSL stocks are traded under the ticker CSJ.STU.
Is CSL stock price growing?▼
CSJ.STU stock has risen by +0.88% compared to the previous week, the month change is a -4.14% fall, over the last year CSL has showed a -34.14% decrease.
When is the next CSL earnings date?▼
CSL is going to release the next earnings report on August 18, 2026.
What were CSL earnings last quarter?▼
CSJ.STU earnings for the last quarter are 3.39 EUR per share, whereas the estimation was 3.48 EUR resulting in a -2.66% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does CSL have?▼
As of April 11, 2026, the company has 29,904 employees.
In which sector is CSL located?▼
CSL operates in the Health Care sector.
When did CSL complete a stock split?▼
CSL has not had any recent stock splits.
Where is CSL headquartered?▼
CSL is headquartered in Melbourne, DE.